Rapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call Transcript |
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Mike Beaulieu - VP, IR and Corporate Communications Rob Spignesi - President and CEO Sean Wirtjes - CFO Conference Call Participants Dan Arias - Stifel Paul Knight - KeyBanc Capital Markets Chad Wiatrowski - TD Cowen Operator Thank you for standing by. My name is RG, and I will be your conference operator today. |
seekingalpha.com |
2025-05-09 18:29:16 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates |
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.31 per share a year ago. |
zacks.com |
2025-05-09 13:20:43 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results |
LEXINGTON, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2025. |
globenewswire.com |
2025-05-09 11:00:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025 |
LEXINGTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2025 financial results prior to the market open on Friday, May 9, 2025. |
globenewswire.com |
2025-04-24 20:15:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants (i) on March 3, 2025, of 50,000 restricted stock units (“RSUs”) of the Company's Class A common stock (“Common Stock”) as a material inducement to employment of one new employee and (ii) on March 10, 2025, of non-qualified stock options to purchase an aggregate of 250,000 shares of Common Stock (the “Options”) and 174,000 RSUs as a material inducement to employment to two new employees. All such equity awards were made under the Company's Inducement Plan, as amended (the “Inducement Plan”) and were approved by a majority of the independent directors of the Board of Directors or a duly authorized committee thereof in accordance with Nasdaq Listing Rule 5635(c)(4). The equity awards are subject to the terms and conditions of the Inducement Plan, and the terms and conditions of the applicable stock option and RSU award agreements covering the grants. |
globenewswire.com |
2025-03-12 18:30:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems, Inc. (RPID) Q4 2024 Earnings Call Transcript |
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q4 2024 Earnings Conference Call February 28, 2025 8:00 AM ET Company Participants Mike Beaulieu – Vice President, Investor Relations and Corporate Communications Rob Spignesi – President and Chief Executive Officer Sean Wirtjes – Chief Financial Officer Conference Call Participants Dan Arias – Stifel Paul Knight – KeyBanc Brendan Smith – TD Cowen Operator Thank you for standing by. My name is Eloisa, and I will be your conference operator today. |
seekingalpha.com |
2025-02-28 12:54:43 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates |
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.26 per share a year ago. |
zacks.com |
2025-02-28 10:41:08 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance |
LEXINGTON, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the fourth quarter and full year ended December 31, 2024. |
globenewswire.com |
2025-02-28 08:30:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany |
Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for collaboration on supply chain efficiencies, services, and joint product development. Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for collaboration on supply chain efficiencies, services, and joint product development. |
globenewswire.com |
2025-02-27 18:15:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences |
LEXINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences. |
globenewswire.com |
2025-02-26 18:15:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025 |
LEXINGTON, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2024 financial results prior to the market open on Friday, February 28, 2025. |
globenewswire.com |
2025-02-20 18:30:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue |
LEXINGTON, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced preliminary unaudited fourth quarter and full year 2024 revenue. |
globenewswire.com |
2025-01-14 18:15:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Present at 43ʳᵈ Annual J.P. Morgan Healthcare Conference |
LEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference. |
globenewswire.com |
2025-01-07 18:05:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference |
LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Stifel 2024 Healthcare Conference. |
globenewswire.com |
2024-11-08 10:00:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems, Inc. (RPID) Q3 2024 Earnings Call Transcript |
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q3 2024 Results Conference Call November 1, 2024 9:00 AM ET Company Participants Michael Beaulieu - CFA, VP, IR & Corporate Communications Robert Spignesi - President & CEO Sean Wirtjes - CFO Conference Call Participants Brendan Smith - TD Cowen Dan Arias - Stifel Operator Thank you for standing by. My name is Novi, and I will be your conference operator today. |
seekingalpha.com |
2024-11-01 14:45:22 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates |
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.31 per share a year ago. |
zacks.com |
2024-11-01 11:10:22 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results |
LEXINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the third quarter ended September 30, 2024. |
globenewswire.com |
2024-11-01 09:00:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024 |
LEXINGTON, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2024 financial results prior to the market open on Friday, November 1, 2024. |
globenewswire.com |
2024-10-23 20:45:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference |
LEXINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Friday, September 6, 2024, in New York City. |
globenewswire.com |
2024-09-03 20:50:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates |
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.33 per share a year ago. |
zacks.com |
2024-08-02 13:11:49 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results |
LEXINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the second quarter ended June 30, 2024. |
globenewswire.com |
2024-08-02 11:00:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024 |
LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2024 financial results prior to the market open on Friday, August 2, 2024. |
globenewswire.com |
2024-07-17 20:30:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates |
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.32 per share a year ago. |
zacks.com |
2024-05-03 13:10:16 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results |
Reports first quarter 2024 total revenue of $5.6 million , representing growth of 11% compared to first quarter 2023 |
globenewswire.com |
2024-05-03 11:00:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024 |
LOWELL, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2024 financial results prior to the market open on Friday, May 3, 2024. |
globenewswire.com |
2024-04-18 20:30:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024 |
Company to give technical presentation on its innovative Growth Direct® Rapid Sterility Application Company to give technical presentation on its innovative Growth Direct® Rapid Sterility Application |
globenewswire.com |
2024-03-19 18:30:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum |
LOWELL, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the virtual KeyBanc Life Sciences & MedTech Investor Forum on March 19, 2024. |
globenewswire.com |
2024-03-12 18:50:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
LOWELL, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that, effective March 4, 2024, the Compensation Committee of the Company's Board of Directors granted non-qualified stock options to purchase 150,000 shares of the Company's Class A common stock (“Common Stock”) and 75,000 restricted stock units (“RSUs”) to a new employee under the Company's 2023 Inducement Plan, as amended (the “2023 Inducement Plan”). |
globenewswire.com |
2024-03-06 20:40:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript |
Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript |
seekingalpha.com |
2024-03-01 15:31:09 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance |
Reports fourth quarter 2023 total revenue of $6.3 million , representing 45% growth compared to fourth quarter 2022 |
globenewswire.com |
2024-03-01 08:30:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences |
LOWELL, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences: |
globenewswire.com |
2024-02-27 18:30:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024 |
LOWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2023 financial results prior to the market open on Friday, March 1, 2024. |
globenewswire.com |
2024-02-20 18:36:00 |
Czytaj oryginał (ang.) |
Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System |
The new Rapid Sterility application includes a novel, proprietary test kit that has been developed for use with the Company's fully automated Growth Direct system and delivers time to organism detection in as little as 12 hours and final time-to-result in as little as one to three days |
globenewswire.com |
2024-01-10 09:22:00 |
Czytaj oryginał (ang.) |